so i went back and listened to the call a second time. i
so i went back and listened to the call a second time. i highly recommend doing it. this time i didn't listen through the filter of expecting the hold to have been lifted - which colored my view, and lead me to be disappointed once i learned it had not been lifted.
to me, Cyrus comes across as extremely credible, thoughtful and very focused. he brings all of the things that NP never had - the things that we have to have to get this thing across the goal line. just the process of running the analysis of all of the indications, market sizes, etc. - and then running them back to NPV and picking the critical path so that we nail the low hanging fruit - that's never been done before - and that was always a concern of mine (the scatter gun approach).
maybe it's because he's following NP - but i am very pleased with how methodical and thoughtful he seems to be. it also is clear that he knows how to spot a valuable compound - and picked this company based on the potential value of Leronlimab - a big validation.
My bottom line is that i think we finally have the guy that can bring it home - it just comes down to timing, and on that point i have no clue. i'm going to take a chill pill for the next couple of months, and focus my sights on 2023. and if something big happens before year-end, all the better.
19
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Private wealth is about to get squeezed from three directions at once: younger heirs, smarter machines and assets that do not fit neatly in the old family-office binder. That is the real backdrop to the Future of Wealth Forum, a new GFTN and Luxembourg House of Financial Technology partnership slated for Luxembourg City on September 27-29, 2027. It is early days,...
Continue Reading
Longevity medicine just got a very large check and an even larger assignment. Hone Health says it has raised $228 million to push physician-led care beyond its roots in hormone optimization, and the split of that financing matters more than the celebrity names attached to it. Only $28 million is described as Series A equity; the other $200 million comes as growth...
Continue Reading
A passcard, a hidden door, and 12,000 square feet of mischief have landed at Somernova. Edge of Elsewhere, the new flagship attraction from Boston-area creative studio Midnight Mansion, is open in Somerville’s Union Square as of November 18, 2026. It is part interactive art installation, part puzzle game, part physical story world. That sounds delightfully odd, which is...
Continue Reading
Remote Controls Are Nobody’s First Suspect A television remote can make the rounds all evening and never see a cloth, which is precisely why Maid Brigade’s cold-and-flu-season reminder lands as common sense rather than revelation. The Scottsdale cleaning company is telling households to look past the usual kitchen counter and bathroom sink routine. Fair enough. People...
Continue Reading
Forklift makers do not usually get to hide a 7.50% borrowing cost behind glossy financing jargon. Hyster-Yale has priced $135 million of convertible senior notes due in 2031, lifting the deal from the originally announced $125 million. There is also an option for initial purchasers to take another $20 million. For NYSE:HY shareholders, this is not a simple debt cleanup....
Continue Reading
Midlife care just became the newest proving ground for DarioHealth’s sales pitch. The company says The Minnesota Star Tribune has expanded its existing relationship to include Dario Women™, a program for employees navigating perimenopause and menopause. Eligible employees are expected to gain access in January 2027. For NASDAQ:DRIO, this is not some grand revenue...
Continue Reading
A corporate-law handoff rarely sets pulses racing, but this one deserves a proper look. Chemours is replacing its long-serving general counsel while keeping the departing executive in the building for four additional months. That is not flashy, and thank goodness for that. In a global chemicals company, legal leadership touches regulation, compliance, governance,...
Continue Reading
A half-billion-dollar buyback authorization can make a stock crowd sit up fast, and Modexus Solutions has plainly chosen that moment. On November 18, 2026, the Racine, Wisconsin-based thermal-management company said its board authorized repurchases of up to $500 million of common stock. For holders of NYSE:MOD, that is a meaningful declaration of intent. It says...
Continue Reading
One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...
Continue Reading
A homeowner's insurance bill has become a louder market signal than a granite countertop. Green Builder Media's latest batch of research, publishing and events is aimed squarely at that uncomfortable truth: housing is no longer judged only by the price on the contract. Buyers, builders, lenders and insurers are being pushed to reckon with what a home costs to own, protect...
Continue Reading
Top 5 Most Recently Viewed Articles
Great American Media to Broadcast 2025 National Christmas Tree Lighting Great American Media is proud to announce that it will serve as the exclusive broadcast home of the 2025 National Christmas Tree Lighting, a cherished event that creates a beautiful sense of community across the nation. This unique celebration, themed "Christmas as It's Meant to Be," is an opportunity...
Continue Reading
Overview of the Lucent Health Data Breach In the wake of a significant data breach, many individuals are left uncertain about the status of their personal information. Lucent Health Solutions, a provider in the healthcare industry, faced a considerable security incident that compromised sensitive data, affecting numerous individuals. It is essential to understand the...
Continue Reading
BofA's Optimistic Forecast for Uber Stock Sets New Target BofA Securities has recently provided a positive outlook for Uber Inc. (NYSE: UBER), increasing its price target for the company’s stock from $88 to $96. With a Buy rating in place, analysts highlight the upcoming earnings report slated for release on October 31, anticipating results that could slightly exceed...
Continue Reading
Endries International Welcomes New CEO Dan Crociata Endries International Inc., a renowned name in the fastener and supply chain solutions industry, has made a significant transition in its leadership. Dan Crociata, who has played a vital role within the company as Chief Financial Officer, has been appointed the Chief Executive Officer. This change marks a new chapter in...
Continue Reading
CIWA Launches Internship Program The California Insurance Wholesalers Association (CIWA) has unveiled an exciting new initiative aimed at cultivating the next generation of insurance professionals. This Internship Program is crafted to provide college students with hands-on experience in the dynamic world of excess and surplus lines insurance. Purpose of the Internship...
Continue Reading